GEJ ADENOCARCINOMA
Clinical trials for GEJ ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GEJ ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GEJ ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug XYA02 takes on tough cancers in first human trial
Disease control Not yet recruitingThis study tests a new biologic drug called XYA02 in 190 adults with advanced solid tumors (including lung, ovarian, and pancreatic cancers) that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumo…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: XYone Therapeutics, Inc • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo aims to shrink stomach cancer before surgery
Disease control Not yet recruitingThis early-phase trial tests whether adding an experimental immunotherapy drug (Retlirafusp alfa) to standard chemotherapy can improve outcomes for people with gastroesophageal junction adenocarcinoma. About 30 patients will receive the drug combination before surgery, and some m…
Matched conditions: GEJ ADENOCARCINOMA
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC